Increased expression and activity of ACLY have been observed in various cancers including glioblastoma, colorectal cancer, BC, and hepatocellular carcinoma, suggesting that targeting ACLY may be an effective approach for anticancer therapy. The gene discussed is ACLY; the disease is hepatocellular carcinoma.